RAPT Therapeutics (RAPT) Assets: 2020-2024
Historic Assets for Therapeutics (RAPT) over the last 5 years, with Sep 2024 value amounting to $108.5 million.
- Therapeutics' Assets fell 45.69% to $108.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $108.5 million, marking a year-over-year decrease of 45.69%. This contributed to the annual value of $173.3 million for FY2023, which is 34.89% down from last year.
- Latest data reveals that Therapeutics reported Assets of $108.5 million as of Q3 2024, which was down 14.72% from $127.2 million recorded in Q2 2024.
- In the past 5 years, Therapeutics' Assets registered a high of $266.2 million during Q4 2022, and its lowest value of $105.9 million during Q1 2021.
- Moreover, its 3-year median value for Assets was $199.7 million (2023), whereas its average is $192.6 million.
- Per our database at Business Quant, Therapeutics' Assets spiked by 77.06% in 2022 and then slumped by 45.69% in 2024.
- Therapeutics' Assets (Quarterly) stood at $119.0 million in 2020, then spiked by 66.96% to $198.6 million in 2021, then spiked by 34.02% to $266.2 million in 2022, then crashed by 34.89% to $173.3 million in 2023, then crashed by 45.69% to $108.5 million in 2024.
- Its Assets stands at $108.5 million for Q3 2024, versus $127.2 million for Q2 2024 and $155.8 million for Q1 2024.